COVID-19 Impact on Bupa

COVID-19 Impact on Bupa

Summary

GlobalData’s 'COVID-19 Impact on Bupa’ report provides a snapshot of the impact on the Bupa in light of the COVID-19 outbreak.

It provides the impact of revised GDP growth estimates on growth prospects of Bupa, exposure of the product portfolio and exposure by country/region due to virus outbreak.

The report brings together GlobalData’s research, modeling and analysis expertise, giving access to information on the projected impacts of the outbreak on the insurer.

This report provides in-depth company analysis, information and insights of COVID-19 impact on Bupa.

Key Highlights

- Exposure of the insurer to regions and countries impacted by COVID-19
- Key lines of businesses across regions where the insurer's books are potentially impacted
- Share of key lines of businesses by country/region in context of COVID-19 impact

Scope

This report provides a comprehensive analysis of the impact of COVID-19 on Bupa -
- It provides insights on Bupa exposure to the regions and businesses impacted by the COVID-19 outbreak.
- It offers an overview of the key business lines of the insurer that could be impacted due to the COVID-19 outbreak.

Reasons to Buy

- Take a strategic view of the business exposure of leading global insurers in COVID-19 outbreak.
- Understand the key factors shaping the growth and profitability outlook of the insurer.